Second, populations with other cardiovascular diseases, such as myocardial infarction, coronary artery disease, atherosclerosis, and stroke, were not included, which could help further determine the specificity of elevated TNFRSF9 in AAA. This evidence concerns the gene TNFRSF9 and myocardial infarction.